Inventor
ROSS SVANTE
SE16 patents
⚠️ This page may combine multiple inventors who share the name “ROSS SVANTE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
13 patentsUS6479497B1Nov 12, 2002
Substituted chroman derivatives
ASTRAZENECA AB16 citations92
US6472423B1Oct 29, 2002
Pharmaceutical composition
ASTRAZENECA AB24 citations92
US6159971ADec 12, 2000
Combination of a 5-HT reuptake inhibitor and a h5-HT1B anatagonist or partial agonist
ASTRAZENECA AB26 citations92
US6387899B1May 14, 2002
Substituted chroman derivatives
ASTRAZENECA AB18 citations90
US6159970ADec 12, 2000
Combination of a monoamine oxidase inhibitor and a h5-HT1B antagonist or partial agonist
ASTRAZENECA AB7 citations73
US6384225B1May 7, 2002
Intermediates in the preparation of substituted chroman derivatives
ASTRAZENECA AB7 citations71
US6159972ADec 12, 2000
Combination of a selective 5-HT1A antagonist and a selective ub. h5-HT.s1B antagonist or partial agonist
ASTRAZENECA AB6 citations62
US6548498B1Apr 15, 2003
Substituted indan derivatives
ASTRAZENECA AB2 citations61
US6410532B2Jun 25, 2002
Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRAZENECA AB0 citations52
US7384943B2Jun 10, 2008
Substituted chroman derivatives
ASTRAZENECA AB0 citations51
US6670359B2Dec 30, 2003
Substituted chroman derivatives
ASTRAZENECA AB0 citations51
US7439356B2Oct 21, 2008
Substituted indan derivatives
ASTRAZENECA AB0 citations50
US6410530B1Jun 25, 2002
Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRAZENECA AB1 citations50